Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin plus two dexamethasone doses for acute pain after septoplasty
IRCT20190325043107N49Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Oct 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of gabapentin and dexamethasone in acute pain (3 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Acute pain. Started Oct 2024; status: completed.
02
Drugs
gabapentindexamethasone
03
Conditions
acute pain
Beyond the preview
Go deeper on IRCT20190325043107N49.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190325043107N49.